Production of interleukin-27 by human neutrophils regulates their function during bacterial infection

European Journal of Immunology

Volumn 42, Issue 12, 2012, Pages 3280-3290

  Rinchai, Darawan ^a   Khaenam, Prasong ^a,b   Kewcharoenwong, Chidchamai ^a   Buddhisa, Surachat ^a   Pankla, Rungnapa ^a,e   Chaussabel, Damien ^b,c   Bancroft, Gregory J ^d   Lertmemongkolchai, Ganjana ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b BENAROYA RESEARCH INSTITUTE   (United States)

^c BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e NARESUAN UNIVERSITY   (Thailand)

Author keywords

Burkholderia pseudomallei; IL 27; Melioidosis; Neutrophil; Sepsis

Indexed keywords

CYTOKINE RECEPTOR ANTAGONIST; INTERLEUKIN 1BETA; INTERLEUKIN 27; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIAL SURVIVAL; BURKHOLDERIA PSEUDOMALLEI; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENETIC TRANSCRIPTION; GRANULOCYTE FUNCTION; HUMAN; IN VITRO STUDY; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MELIOIDOSIS; MONOCYTE; NEUTROPHIL; NEUTROPHIL FUNCTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PURIFICATION; RESPIRATORY BURST; SEPSIS; SERODIAGNOSIS;

ADOLESCENT; ADULT; AGED; BURKHOLDERIA PSEUDOMALLEI; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1BETA; INTERLEUKINS; MACROPHAGES; MALE; MELIOIDOSIS; MIDDLE AGED; MONOCYTES; NEUTROPHILS; RESPIRATORY BURST; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84871343453     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242526     Document Type: Article

References (41)

1. Cohen, J., The immunopathogenesis of sepsis. Nature 2002. 420: 885-891.
2. Hotchkiss, R. S. and Karl, I. E., The pathophysiology and treatment of sepsis. N. Engl. J. Med. 2003. 348: 138-150.
3. Wiersinga, W. J. and van der Poll, T., Immunity to Burkholderia pseudomallei. Curr. Opin. Infect. Dis. 2009. 22: 102-108.
4. Wiersinga, W. J., van der Poll, T., White, N. J., Day, N. P. and Peacock, S. J., Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat. Rev. Microbiol. 2006. 4: 272-282.
5. Wirtz, S., Tubbe, I., Galle, P. R., Schild, H. J., Birkenbach, M., Blumberg, R. S. and Neurath, M. F., Protection from lethal septic peritonitis by neutralizing the biological function of interleukin 27. J. Exp. Med. 2006. 203: 1875-1881.
6. Takeda, K., Kaisho, T. and Akira, S., Toll-like receptors. Annu. Rev. Immunol. 2003. 21: 335-376.
7. Cheng, A. C. and Currie, B. J., Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 2005. 18: 383-416.
8. White, N. J., Melioidosis. Lancet 2003. 361: 1715-1722.
9. Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche J. et al., Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit. Care Med. 2004. 32: 858-873.
10. Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J. et al., 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 2003. 31: 1250-1256.
11. Pankla, R., Buddhisa, S., Berry, M., Blankenship, D. M., Bancroft, G. J., Banchereau, J., Lertmemongkolchai, G. et al., Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis. Genome Biol. 2009. 10: R127.
12. Pflanz, S., Timans, J. C., Cheung, J., Rosales, R., Kanzler, H., Gilbert, J., Hibbert, L. et al., IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002. 16: 779-790.
13. Devergne, O., Hummel, M., Koeppen, H., Le Beau, M. M., Nathanson, E. C., Kieff, E. and Birkenbach, M., A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol. 1996. 70: 1143-1153.
14. Wirtz, S., Becker, C., Fantini, M. C., Nieuwenhuis, E. E., Tubbe, I., Galle, P. R., Schild, H. J. et al., EBV-induced gene 3 transcription is induced by TLR signaling in primary dendritic cells via NF-kappa B activation. J. Immunol. 2005. 174: 2814-2824.
15. Liu, J., Guan, X. and Ma, X., Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-gamma-mediated pathways. J. Exp. Med. 2007. 204: 141-152.
16. Smits, H. H., van Beelen, A. J., Hessle, C., Westland, R., de Jong, E., Soeteman, E., Wold, A. et al., Commensal Gram-negative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Th1 development. Eur. J. Immunol. 2004. 34: 1371-1380.
17. Pflanz, S., Hibbert, L., Mattson, J., Rosales, R., Vaisberg, E., Bazan, J. F., Phillips, J. H. et al., WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 2004. 172: 2225-2231.
18. Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. et al., Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992. 101: 1644-1655.
19. Haque, A., Easton, A., Smith, D., O'Garra, A., Van Rooijen, N., Lertmemongkolchai, G., Titball, R. W. et al., Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection. J. Infect. Dis. 2006. 193: 370-379.
20. Haque, A., Chu, K., Easton, A., Stevens, M. P., Galyov, E. E., Atkins, T., Titball, R. et al., A live experimental vaccine against Burkholderia pseudomallei elicits CD4+ T cell-mediated immunity, priming T cells specific for 2 type III secretion system proteins. J. Infect. Dis. 2006. 194: 1241-1248.
21. Hall, A. O., Silver, J. S. and Hunter, C. A., The immunobiology of IL-27. Adv. Immunol. 2012. 115: 1-44.
22. Schneider, R., Yaneva, T., Beauseigle, D., El-Khoury, L. and Arbour, N., IL-27 increases the proliferation and effector functions of human naive CD8+ T lymphocytes and promotes their development into Tc1 cells. Eur. J. Immunol. 2011. 41: 47-59.
23. Aderem, A. and Ulevitch, R. J., Toll-like receptors in the induction of the innate immune response. Nature 2000. 406: 782-787.
24. Medzhitov, R. and Janeway, C., Jr., The Toll receptor family and microbial recognition. Trends Microbiol. 2000. 8: 452-456.
25. Villarino, A. V., Huang, E. and Hunter, C. A., Understanding the pro- and anti-inflammatory properties of IL-27. J. Immunol. 2004. 173: 715-720.
26. Pirhonen, J., Siren, J., Julkunen, I. and Matikainen, S., IFN-alpha regulates Toll-like receptor-mediated IL-27 gene expression in human macrophages. J. Leukoc. Biol. 2007. 82: 1185-1192.
27. Veckman, V. and Julkunen, I., Streptococcus pyogenes activates human plasmacytoid and myeloid dendritic cells. J. Leukoc. Biol. 2008. 83: 296-304.
28. Schnurr, M., Toy, T., Shin, A., Wagner, M., Cebon, J. and Maraskovsky, E., Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. Blood 2005. 105: 1582-1589.
29. Goriely, S., Neurath, M. F. and Goldman, M., How microorganisms tip the balance between interleukin-12 family members. Nat. Rev. Immunol. 2008. 8: 81-86.
30. van der Poll, T. and Opal, S. M., Host-pathogen interactions in sepsis. Lancet Infect. Dis. 2008. 8: 32-43.
31. Abe, R., Oda, S., Sadahiro, T., Nakamura, M., Hirayama, Y., Tateishi, Y., Shinozaki, K. et al., Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia. Crit. Care 2010. 14: R27.
32. Li, J. P., Wu, H., Xing, W., Yang, S. G., Lu, S. H., Du, W. T., Yu, J. X. et al., Interleukin-27 as a negative regulator of human neutrophil function. Scand. J. Immunol. 2010. 72: 284-292.
33. Nicholson, S. E., De Souza, D., Fabri, L. J., Corbin, J., Willson, T. A., Zhang, J. G., Silva, A. et al., Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc. Natl. Acad. Sci. USA 2000. 97: 6493-6498.
34. Villarino, A. V., Tato, C. M., Stumhofer, J. S., Yao, Z., Cui, Y. K., Hennighausen, L., O'Shea, J. J. et al., Helper T-cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals. J. Exp. Med. 2007. 204: 65-71.
35. Simpson, A. J., Smith, M. D., Weverling, G. J., Suputtamongkol, Y., Angus, B. J., Chaowagul, W., White, N. J. et al., Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis. J. Infect. Dis. 2000. 181: 621-625.
36. Friedland, J. S., Suputtamongkol, Y., Remick, D. G., Chaowagul, W., Strieter, R. M., Kunkel, S. L., White, N. J. et al., Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection. Infect. Immun. 1992. 60: 2402-2408.
37. Bazzoni, F., Tamassia, N., Rossato, M. and Cassatella, M. A., Understanding the molecular mechanisms of the multifaceted IL-10-mediated anti-inflammatory response: lessons from neutrophils. Eur. J. Immunol. 2010. 40: 2360-2368.
38. Rittirsch, D., Flierl, M. A. and Ward, P. A., Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 2008. 8: 776-787.
39. Gagro, A., Servis, D., Cepika, A. M., Toellner, K. M., Grafton, G., Taylor, D. R., Branica, S. et al., Type I cytokine profiles of human naive and memory B lymphocytes: a potential for memory cells to impact polarization. Immunology 2006. 118: 66-77.
40. Tippayawat, P., Pinsiri, M., Rinchai, D., Riyapa, D., Romphruk, A., Gan, Y. H., Houghton, R. L. et al., Burkholderia pseudomallei proteins presented by monocyte-derived dendritic cells stimulate human memory T cells in vitro. Infect. Immun. 2011. 79: 305-313.
41. Chanchamroen, S., Kewcharoenwong, C., Susaengrat, W., Ato, M. and Lertmemongkolchai, G., Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects. Infect. Immun. 2009. 77: 456-463.